Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,360.50
-39.50 (-0.73%)
May 4, 2026, 3:30 PM IST
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 645.65 billion as of May 4, 2026. Its market cap has increased by 11.64% in one year.
Market Cap
645.65B
Enterprise Value
622.34B
Revenue
142.53B
Ranking
n/a
PE Ratio
27.23
Stock Price
5,360.50
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 645.65B, an increase of 290.82%. That is a compound annual growth rate of 14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 645.65B | -1.93% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.73T |
| Cipla | 1.08T |
| Mankind Pharma | 932.08B |
| Zydus Lifesciences | 897.46B |
| Aurobindo Pharma | 807.02B |
| Glenmark Pharmaceuticals | 679.06B |
| Laurus Labs | 594.36B |
| Ipca Laboratories | 388.40B |